A Randomized Phase III Study of Concomitant and Adjuvant Temozolomide and Radiotherapy For Newly Diagnosed Glioblastoma Multiforme

Primary Chemotherapy with Temozolomide vs. Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study.

A Randomized Phase III Study of Temozolomide and Short-Course Radiation vs. Short-Course Radiation Alone in the Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients.

A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

A Phase III Trial of Marizomib in Combination with Standard Temozolomide-Based Radiochemotherapy versus Standard Temozolomide-Based Radiochemotherapy Alone in Patients with Newly-Diagnosed Glioblastoma

Disease Site	Trial Code	Patients Accrued	Patients - Blocks	Patients - Slides	Patients - Blocks and/or Slides
BRAIN	CE3	168	73	131	149
BRAIN	CE5	82	2	2	4
BRAIN	CE6	562	340	499	518
BRAIN	CE7	Open Trial	0	0	0
BRAIN	CE8	301	0	0	0

(Core size is 0.6 mm)

Disease Site	Trial Code	Patients Accrued	TMA Blocks	Patients on TMA Blocks
BRAIN	CE3	168	0	0
BRAIN	CE5	82	0	0
BRAIN	CE6	562	5	260
BRAIN	CE7	Open Trial	0	0
BRAIN	CE8	301	0	0

Disease Site	Trial Code	Patients Accrued	Patients - Whole Blood	Patients - Cellular Component of Blood	Patients - DNA extracted from Blood	Patients - RNA extracted from Blood	Patients - Plasma	Patients - Serum	Patients - Urine	Patients - Buccal
BRAIN	CE3	168	0	0	0	0	0	0	0	0
BRAIN	CE5	82	3	0	0	0	0	3	0	0
BRAIN	CE6	562	0	0	0	0	0	0	0	0
BRAIN	CE7	Open Trial	127	0	0	0	127	104	104	0
BRAIN	CE8	301	0	0	0	0	3	4	0	0